Under the premise that “animation is the greatest form of visual storytelling,” Travis Blaise co-founded the SketchToAnimate initiative, where he is also the director of the upcoming ARC series and instructor. Through that platform, he has created workshops, tutorials, and online classes covering character design, animation, storyboarding, and building an animation portfolio.

In 2008, he was an adjunct professor for an experimental 2D animation class at CalArts (California, U.S.). From 2017 to 2021, he was a mentor, instructor, and adjunct professor at DigiPen Studios, training students in animation and storyboarding. His latest work was as a storyboard artist on the movie Mufasa (2024).

With over 34 years of experience, Travis Blaise has participated in a wide range of movies and TV shows throughout his career in storyboard artistry, including Disenchantment (2021), Big Mouth (2017), Disney’s Penn Zero (2014), and his animation work with Brother Bear (2003), Lilo & Stitch (2002), Mulan (1998), and The Lion King (1994). He worked for Disney from 1990 to 2004, where he served as an in-between artist and animator in films and video games. After his time at Disney, he worked for studios such as Cartoon Network, The Walt Disney Company, Nickelodeon Animation Studio, Netflix, and Warner Bros.

He is a global lecturer and speaker on the production of digital art, animation, and storytelling projects at CalArts, DigiPen, Toon Boom, Wacom, Disney, the Orlando Museum of Art, the Annecy Festival, and the Bangkok Comic Con, to name a few.

Travis Blaised joined Tecnológico de Monterrey as a Distinguished Visiting Professor in Animation and Storytelling for the School of Architecture, Art and Design. 

• Illustration, Ringling School of Art and Design
• Walt Disney Feature Animation Florida (two internships)

• Latest tutorials and courses from Travis Blaise about storytelling, animation, and storyboards: https://sketchtoanimate.com/

Under the premise that “animation is the greatest form of visual storytelling,” Travis Blaise co-founded the SketchToAnimate initiative, where he is also the director of the upcoming ARC series and instructor. Through that platform, he has created workshops, tutorials, and online classes covering character design, animation, storyboarding, and building an animation portfolio.

In 2008, he was an adjunct professor for an experimental 2D animation class at CalArts (California, U.S.). From 2017 to 2021, he was a mentor, instructor, and adjunct professor at DigiPen Studios, training students in animation and storyboarding. His latest work was as a storyboard artist on the movie Mufasa (2024).

With over 34 years of experience, Travis Blaise has participated in a wide range of movies and TV shows throughout his career in storyboard artistry, including Disenchantment (2021), Big Mouth (2017), Disney’s Penn Zero (2014), and his animation work with Brother Bear (2003), Lilo & Stitch (2002), Mulan (1998), and The Lion King (1994). He worked for Disney from 1990 to 2004, where he served as an in-between artist and animator in films and video games. After his time at Disney, he worked for studios such as Cartoon Network, The Walt Disney Company, Nickelodeon Animation Studio, Netflix, and Warner Bros.

He is a global lecturer and speaker on the production of digital art, animation, and storytelling projects at CalArts, DigiPen, Toon Boom, Wacom, Disney, the Orlando Museum of Art, the Annecy Festival, and the Bangkok Comic Con, to name a few.

Travis Blaised joined Tecnológico de Monterrey as a Distinguished Visiting Professor in Animation and Storytelling for the School of Architecture, Art and Design. 

• Illustration, Ringling School of Art and Design
• Walt Disney Feature Animation Florida (two internships)

• Latest tutorials and courses from Travis Blaise about storytelling, animation, and storyboards: https://sketchtoanimate.com/

Dr. Husted's extensive research and teaching experience lies in the areas of business and public policy, business ethics, corporate social responsibility, and corporate sustainability. He has published widely on business topics and is one of the most prolific authors in business ethics. He has published academic articles in journals such as Organization Science, the Strategic Management Journal, the Journal of International Business Studies, the Journal of Policy Analysis and Management, Business Ethics Quarterly, and Business & Society, amongst others. He is a member of the SNII (National System of Researchers), Level III, Conahcyt, and deputy editor of the journal Organization & Environment.

He has had an outstanding academic career as a professor and researcher at Tecnológico de Monterrey since 1990, as well as foreign institutions such as the IE Business School in Madrid and the Schulich Business School at York University in Toronto.

He is currently the Leader of the Research Group (GI) in Conscious Business Development at the Tecnológico de Monterrey Business School and continues his prolific career as Distinguished Professor in Business and Society.
 

• Ph.D., Business Administration, University of California, Berkeley
• Juris Doctor, Brigham Young University
• MBA, Brigham Young University

• Husted, B.; de Sousa-Filho, M. (2019) "Board structure and environmental, social, and governance disclosure in Latin America". Journal of Business Research, 102, 220-227
• Mohammad, S., Husted, B.W. (2019) "Law-abiding organizational climates in developing countries: The role of institutional factors and socially responsible organizational practices". Business Ethics, 28 (4) 476-493
• Bakker,F.; Crane, A.; Henriques, I.; Husted, B. (2019) "Publishing Interdisciplinary Research in Business & Society". Business and Society, 58 (3) 443-452
• Bapuji, Hari, Husted, B.; Jane Lu, and Raza Mir, (2018) "Value creation, appropriation and distribution: How firms contribute to societal economic inequality". Business and Society, 57 (6) 983-1009
• Barnett, M., Henriques, I. & Husted, B. (2018) "Governing the void between stakeholder management and sustainability". Advances in Strategic Management, 38, 121-143

More publications

Dr. Husted's extensive research and teaching experience lies in the areas of business and public policy, business ethics, corporate social responsibility, and corporate sustainability. He has published widely on business topics and is one of the most prolific authors in business ethics. He has published academic articles in journals such as Organization Science, the Strategic Management Journal, the Journal of International Business Studies, the Journal of Policy Analysis and Management, Business Ethics Quarterly, and Business & Society, amongst others. He is a member of the SNII (National System of Researchers), Level III, Conahcyt, and deputy editor of the journal Organization & Environment.

He has had an outstanding academic career as a professor and researcher at Tecnológico de Monterrey since 1990, as well as foreign institutions such as the IE Business School in Madrid and the Schulich Business School at York University in Toronto.

He is currently the Leader of the Research Group (GI) in Conscious Business Development at the Tecnológico de Monterrey Business School and continues his prolific career as Distinguished Professor in Business and Society.
 

• Ph.D., Business Administration, University of California, Berkeley
• Juris Doctor, Brigham Young University
• MBA, Brigham Young University

• Husted, B.; de Sousa-Filho, M. (2019) "Board structure and environmental, social, and governance disclosure in Latin America". Journal of Business Research, 102, 220-227
• Mohammad, S., Husted, B.W. (2019) "Law-abiding organizational climates in developing countries: The role of institutional factors and socially responsible organizational practices". Business Ethics, 28 (4) 476-493
• Bakker,F.; Crane, A.; Henriques, I.; Husted, B. (2019) "Publishing Interdisciplinary Research in Business & Society". Business and Society, 58 (3) 443-452
• Bapuji, Hari, Husted, B.; Jane Lu, and Raza Mir, (2018) "Value creation, appropriation and distribution: How firms contribute to societal economic inequality". Business and Society, 57 (6) 983-1009
• Barnett, M., Henriques, I. & Husted, B. (2018) "Governing the void between stakeholder management and sustainability". Advances in Strategic Management, 38, 121-143

More publications

Dr. Alejandro Madrigal began his medical studies at the Universidad Nacional Autónoma de México (UNAM) and continued his training at some of the world’s top universities. He is currently a Professor of Hematology at UCL, a Faculty of Excellence professor at the Tecnológico de Monterrey, and a Professor Emeritus of the National System of Researchers in Mexico. He was an Honorary Affiliated Physician at the Royal Free Hospital (UK) and UCL Cancer Institute.

He founded and served as the first scientific director of the Anthony Nolan Research Institute in London, which supports people with blood cancer or disorders. He has trained numerous doctors and scientists and has developed multiple Registers for Unrelated Stem Cell Donors (USCD) and cord blood collection centers. His research focuses on how to improve immunotherapy and stem cell transplantation to make cancer cell therapy more accessible, particularly for minorities. He is a Fellow of the Academy of Medical Sciences and a member of the Royal College of Physicians (UK) and holds honorary memberships in the National Academy of Medicine (Mexico) and the Mexican Academy of Sciences.

He has secured multiple grants and has funded students and researchers. He has published over 570 papers, with more than 17,000 citations in journals like Nature and The Lancet. In 2023, he received the Carlos Slim Health Award for Lifetime Achievement in Research for his work on health issues in Latin America. He also holds four honorary doctorates and was appointed an Officer of the Most Excellent Order of the British Empire (OBE) by Queen Elizabeth II in 2022.

Alejandro Madrigal joined Tecnológico de Monterrey as a FEMSA Distinguished Professor in Hematology and Cellular Therapy for the School of Medicine and Health Sciences.

• Postdoctoral studies, Harvard University
• Postdoctoral studies, Stanford University
• Doctoral studies, University College London (UCL)
• Medicine and specialty in Internal Medicine, Universidad Nacional Autónoma de México (UNAM)

• Madrigal, J. A., Chávez, M., & Mayani, H. (2022). Advanced Cell Therapy: Beyond the last Frontier in the Treatment of Cancer. A Historical Perspective Emphasizing the Work of Nobel Prize Laureates. Archives Of Medical Research, 53(8), 747-752. https://doi.org/10.1016/j.arcmed.2022.11.006

• Ros-Soto, J., Snowden, J. A., Szydlo, R., Nicholson, E., Madrigal, A., Easdale, S., Potter, M., Ethell, M., & Anthias, C. (2022). Outcomes After Donor Lymphocyte Infusion in Patients With Hematological Malignancies: Donor Characteristics Matter. Transplantation And Cellular Therapy, 28(4), 183.e1-183.e8. https://doi.org/10.1016/j.jtct.2022.01.022

• Petersdorf, E. W., Gooley, T., Volt, F., Kenzey, C., Madrigal, A., McKallor, C., Querol, S., Rafii, H., Rocha, V., Tamouza, R., Chabannon, C., Ruggeri, A., & Gluckman, É. (2020). Use of the HLA-B leader to optimize cord blood transplantation. Haematologica, 106(12), 3107-3114. https://doi.org/10.3324/haematol.2020.264424

• Querol, S., Rubinstein, P., & Madrigal, A. (2021). The wider perspective: cord blood banks and their future prospects. British Journal Of Haematology, 195(4), 507-517. https://doi.org/10.1111/bjh.17468

• Wynn, L. A., & Madrigal, A. (2021). Predictive analytics and cord blood banking: toward utilization-based unit selection. Cytotherapy, 23(7), 641-646. https://doi.org/10.1016/j.jcyt.2021.01.002

More information

Dr. Alejandro Madrigal began his medical studies at the Universidad Nacional Autónoma de México (UNAM) and continued his training at some of the world’s top universities. He is currently a Professor of Hematology at UCL, a Faculty of Excellence professor at the Tecnológico de Monterrey, and a Professor Emeritus of the National System of Researchers in Mexico. He was an Honorary Affiliated Physician at the Royal Free Hospital (UK) and UCL Cancer Institute.

He founded and served as the first scientific director of the Anthony Nolan Research Institute in London, which supports people with blood cancer or disorders. He has trained numerous doctors and scientists and has developed multiple Registers for Unrelated Stem Cell Donors (USCD) and cord blood collection centers. His research focuses on how to improve immunotherapy and stem cell transplantation to make cancer cell therapy more accessible, particularly for minorities. He is a Fellow of the Academy of Medical Sciences and a member of the Royal College of Physicians (UK) and holds honorary memberships in the National Academy of Medicine (Mexico) and the Mexican Academy of Sciences.

He has secured multiple grants and has funded students and researchers. He has published over 570 papers, with more than 17,000 citations in journals like Nature and The Lancet. In 2023, he received the Carlos Slim Health Award for Lifetime Achievement in Research for his work on health issues in Latin America. He also holds four honorary doctorates and was appointed an Officer of the Most Excellent Order of the British Empire (OBE) by Queen Elizabeth II in 2022.

Alejandro Madrigal joined Tecnológico de Monterrey as a FEMSA Distinguished Professor in Hematology and Cellular Therapy for the School of Medicine and Health Sciences.

• Postdoctoral studies, Harvard University
• Postdoctoral studies, Stanford University
• Doctoral studies, University College London (UCL)
• Medicine and specialty in Internal Medicine, Universidad Nacional Autónoma de México (UNAM)

• Madrigal, J. A., Chávez, M., & Mayani, H. (2022). Advanced Cell Therapy: Beyond the last Frontier in the Treatment of Cancer. A Historical Perspective Emphasizing the Work of Nobel Prize Laureates. Archives Of Medical Research, 53(8), 747-752. https://doi.org/10.1016/j.arcmed.2022.11.006

• Ros-Soto, J., Snowden, J. A., Szydlo, R., Nicholson, E., Madrigal, A., Easdale, S., Potter, M., Ethell, M., & Anthias, C. (2022). Outcomes After Donor Lymphocyte Infusion in Patients With Hematological Malignancies: Donor Characteristics Matter. Transplantation And Cellular Therapy, 28(4), 183.e1-183.e8. https://doi.org/10.1016/j.jtct.2022.01.022

• Petersdorf, E. W., Gooley, T., Volt, F., Kenzey, C., Madrigal, A., McKallor, C., Querol, S., Rafii, H., Rocha, V., Tamouza, R., Chabannon, C., Ruggeri, A., & Gluckman, É. (2020). Use of the HLA-B leader to optimize cord blood transplantation. Haematologica, 106(12), 3107-3114. https://doi.org/10.3324/haematol.2020.264424

• Querol, S., Rubinstein, P., & Madrigal, A. (2021). The wider perspective: cord blood banks and their future prospects. British Journal Of Haematology, 195(4), 507-517. https://doi.org/10.1111/bjh.17468

• Wynn, L. A., & Madrigal, A. (2021). Predictive analytics and cord blood banking: toward utilization-based unit selection. Cytotherapy, 23(7), 641-646. https://doi.org/10.1016/j.jcyt.2021.01.002

More information

Dr. Carlos Aguilar is an expert on the pathophysiology, treatment, and management of dyslipidemias and type 2 diabetes in Mexico. He is a surgeon specializing in Internal Medicine and Endocrinology and holds a doctorate in Medical Research. His main contributions include: participating in the identification of new genes involved in the pathophysiology of Familial Combined Hyperlipidemia; being part of the team that conducted the first genome-wide study to identify the genetic variants that modulate plasma lipid levels in Mexicans; and helping identify the R230C variant of the ABC-A1 transporter (a variant specific to Amerindian populations) as a determinant of HDL cholesterol concentrations in Mexicans, among others.

Since 1996, he has been deputy chief of the Department of Endocrinology and Metabolism of the National Institute of Medical Sciences and Nutrition (Mexico) and has been coordinator of the
Ethics Committee of the National Institute of Medical Sciences and Nutrition since 2012. He is also a member of the National Academy of Medicine and has held positions such as director of examinations of the Mexican Board of Endocrinology and president of the Mexican Society of Nutrition and Endocrinology. 

Carlos Aguilar is a Level III researcher with the National System of Researchers in Mexico and a Level F researcher with the National Institutes of Health in the U.S. His scientific output is prolific, with more than 540 articles published in peer-reviewed and/or indexed journals and 66,711 citations. His research focuses on the peculiarities of metabolic diseases in Mexican mestizos, such as the pathophysiology of primary dyslipidemias, the epidemiology of type 2 diabetes, the development of predictive models for type 2 diabetes and its comorbidities, and the characterization of the mechanisms by which certain genetic variants are associated with type 2 diabetes. He received Mexico’s National Science Award in 2018.

Carlos Aguilar joined Tecnológico de Monterrey as Distinguished Visiting Professor in Epidemiology at the School of Medicine and Health Sciences.

• Doctorate in Medical Research, Escuela Superior de Medicina, Instituto Politécnico Nacional
• Research stay at the Division of Atherosclerosis and Lipid Research, Washington University
• Specialty in Endocrinology, Instituto Nacional de la Nutrición
• Specialty in Internal Medicine, Instituto Nacional de la Nutrición
• Medical Surgeon, Universidad Nacional Autónoma de México (UNAM)

• Rojas-Martínez R, Escamilla-Nuñez C, Aguilar-Salinas CA, Castro-Porras L, Romero-Martínez M, Lazcano-Ponce E. Trends in the mortality of diabetes in Mexico from 1998 to 2022: a joinpoint regression and age-period-cohort effect analysis. Public Health. 2023 Dec 5;226:128-137. doi: 10.1016/j.puhe.2023.10.038
• Basto-Abreu A, López-Olmedo N, Rojas-Martínez R, Aguilar-Salinas CA, Moreno-Banda GL, Carnalla M, Rivera JA, Romero-Martinez M, Barquera S, Barrientos-Gutiérrez T. Prevalencia de prediabetes y diabetes en México: Ensanut 2022. Salud Publica Mex. 2023 Jun 13;65:s163-s168. doi: 10.21149/14832
• Rojas-Martínez R, Escamilla-Núñez C, Castro-Porras L, Basto-Abreu A, Barrientos-Gutiérrez T, Romero-Martínez M, Aguilar-Salinas C. Tamizaje, prevalencia, diagnóstico previo, tratamiento y control de hipertensión, hipercolesterolemia y diabetes en adultos mexicanos. Ensanut 2022. Salud Publica Mex. 2023 Nov 13;65(6, nov-dic):685-696. doi: 10.21149/15060
• Rivera-Alcántara JA, Esparza-Hurtado N, Galán-Ramírez GA, Cruz-Bautista I, Mehta R, Aguilar-Salinas CA, Martagon AJ. A systematic review of biobanks in Latin America: Strengths and limitations for biomedical research. Int J Biol Markers. 2024 Apr 13:3936155241239672. doi: 10.1177/03936155241239672. PMID: 38613331.
• Vargas-Vázquez A, Fermín-Martínez CA, Antonio-Villa NE, Fernández-Chirino L, Ramírez-García D, Dávila-López G, Díaz-Sánchez JP, Aguilar-Salinas CA, Seiglie JA, Bello-Chavolla OY. Insulin resistance potentiates the effect of remnant cholesterol on cardiovascular mortality in individuals without diabetes. Atherosclerosis. 2024 Mar 13:117508. doi: 10.1016/j.atherosclerosis.2024.117508. PMID: 38570208.
• Sohail M, Palma-Martínez MJ, Chong AY, Quinto-Cortés CD, Barberena-Jonas C, Medina-Muñoz SG, Ragsdale A, Delgado-Sánchez G, Cruz-Hervert LP, Ferreyra-Reyes L, Ferreira-Guerrero E, Mongua-Rodríguez N, Canizales-Quintero S, Jimenez-Kaufmann A, Moreno-Macías H, Aguilar-Salinas CA, Auckland K, Cortés A, Acuña-Alonzo V, Gignoux CR, Wojcik GL, Ioannidis AG, Fernández-Valverde SL, Hill AVS, Tusié-Luna MT, Mentzer AJ, Novembre J, García-García L, Moreno-Estrada. Mexican Biobank advances population and medical genomics of diverse ancestries. Nature. 2023 Oct 11. doi: 10.1038/s41586-023-06560-0 

More information